TRCT
ASTH icon

Tower Research Capital (TRC)’s Astrana Health ASTH Stock Holding History

Tower Research Capital (TRC)’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$167K Buy
3,596
+1,592
+79% +$57.3K ﹤0.01% 1828
2026
Q1 		$49.1K Buy
2,004
+801
+67% +$19K ﹤0.01% 2750
2025
Q4 		$29.8K Sell
1,203
-1,896
-61% -$50.3K ﹤0.01% 2812
2025
Q3 		$87.9K Sell
3,099
-1,506
-33% -$40.8K ﹤0.01% 2108
2025
Q2 		$115K Buy
4,605
+3,517
+323% +$99K ﹤0.01% 2267
2025
Q1 		$33.7K Buy
1,088
+424
+64% +$14.1K ﹤0.01% 2526
2024
Q4 		$20.9K Sell
664
-3
-0.4% -$142 ﹤0.01% 3150
2024
Q3 		$38.6K Sell
667
-6,004
-90% -$295K ﹤0.01% 2870
2024
Q2 		$271K Buy
6,671
+5,453
+448% +$216K ﹤0.01% 1841
2024
Q1 		$51.1K Sell
1,218
-10,618
-90% -$414K ﹤0.01% 2264
2023
Q4 		$453K Buy
11,836
+8,902
+303% +$296K 0.01% 1437
2023
Q3 		$90.5K Buy
2,934
+763
+35% +$26.3K ﹤0.01% 2056
2023
Q2 		$68.6K Buy
2,171
+1,171
+117% +$40.2K ﹤0.01% 2318
2023
Q1 		$36K Buy
1,000
+477
+91% +$16.7K ﹤0.01% 2822
2022
Q4 		$16K Sell
523
-7,191
-93% -$231K ﹤0.01% 3388
2022
Q3 		$301K Buy
7,714
+5,825
+308% +$267K ﹤0.01% 1550
2022
Q2 		$73K Buy
1,889
+447
+31% +$17K ﹤0.01% 2544
2022
Q1 		$70K Sell
1,442
-2,060
-59% -$106K ﹤0.01% 2467
2021
Q4 		$258K Sell
3,502
-1,288
-27% -$106K ﹤0.01% 1582
2021
Q3 		$436K Buy
4,790
+3,707
+342% +$315K 0.01% 1091
2021
Q2 		$68K Sell
1,083
-280
-21% -$10.4K ﹤0.01% 2765
2021
Q1 		$37K Buy
1,363
+163
+14% +$3.92K ﹤0.01% 3382
2020
Q4 		$22K Sell
1,200
-11,538
-91% -$207K ﹤0.01% 3819
2020
Q3 		$229K Buy
12,738
+5,556
+77% +$95.8K ﹤0.01% 2450
2020
Q2 		$119K Buy
+7,182
New +$113K ﹤0.01% 2310
2020
Q1 		– Sell
-4,123
Closed -$76K – 4036
2019
Q4 		$76K Buy
+4,123
New +$68.4K 0.01% 1108
2019
Q3 		– Sell
-3,414
Closed -$57K – 4576
2019
Q2 		$57K Buy
3,414
+3,203
+1,518% +$58.1K ﹤0.01% 1517
2019
Q1 		$4K Buy
+211
New +$4.05K ﹤0.01% 3211

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Tower Research Capital (TRC)'s ASTH Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Astrana Health (ASTH) stake by 79% in Q2 2026, buying an estimated $57.3K and bringing the position to 3,596 shares worth $167K. The position accounts for ﹤0.01% of the portfolio, ranked #1828.

Tower Research Capital (TRC) first reported a position in ASTH in Q1 2019 and has held it in 28 quarters since. The position peaked at $453K in Q4 2023. 210 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Tower Research Capital (TRC) held 3,596 shares of Astrana Health worth $167K as of Q2 2026.
  • Tower Research Capital (TRC) bought 1,592 Astrana Health shares in Q2 2026, an estimated $57.3K.
  • Astrana Health made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #1828 holding.
  • Tower Research Capital (TRC) first reported a position in Astrana Health in Q1 2019 and has held it in 28 quarters since.
  • Tower Research Capital (TRC)'s Astrana Health position peaked at $453K in Q4 2023.
  • 210 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.